The practical payer contract rarely ends with one signed document.1
It may include a participation agreement, provider manual, fee schedule, network attachment, amendment, portal notice, and incorporated policy. Prime Therapeutics states that its July 2026 manual forms part of its participation agreement, supersedes prior editions, and can change at the company’s discretion.1
The structure creates an executive problem. Legal may review the agreement, operations may manage workflow, finance may track reimbursement, and credentialing may monitor network status. The enterprise bears the combined result even when no one owns the full relationship.
Create one controlled contract record
Maintain the signed agreement, every amendment, applicable manual, fee schedule, network term, portal communication, and effective date in one controlled register. The organization should be able to identify the rule that governed a transaction when it occurred.
This work cannot stop with storage. Prime places responsibility for compliance with its agreement and revised manual on the participating pharmacy.2 Medicare Part D rules likewise require contracts with downstream entities to preserve federal access to records and impose specified compliance duties.3
Translate terms into accountable controls
- Assign an owner. Name the person responsible for each material duty and deadline.
- Define the process. Connect the contract term to the workflow that performs it.
- Identify the proof. State which record demonstrates performance.
- Set a review cycle. Test the control before a payer, regulator, or accreditor does.
- Build an escalation path. Specify when a financial, compliance, or network issue reaches executive leadership.
Network eligibility, credentialing, reimbursement, audits, inventory sourcing, documentation, accreditation, and termination rights all need that treatment. Federal drug supply law adds another layer by requiring dispensers to maintain specified transaction information and related statements for at least six years.4
Model economics before adding volume
Claim volume does not establish contract value. Leaders should model ingredient reimbursement, professional compensation, fees, recoupment exposure, payment timing, administrative labor, accreditation costs, and the resources needed to remain compliant.
Prime’s current manual warns that noncompliance may lead to corrective action, payment suspension, recoupment, or network termination.5 Those consequences belong in the contract economics. Revenue that consumes contribution margin or creates unpriced risk is not sustainable growth.
Treat every amendment as operational change
A revised manual should trigger a controlled review. Leadership should ask what changed, when the change takes effect, which workflows it affects, who owns implementation, what training or technology is required, and how the organization will prove completion.
Define escalation thresholds before a dispute arises. Reimbursement deterioration, credentialing delay, unexplained claim behavior, missing documentation, and termination risk should move through an established path rather than an improvised email chain.
Turn contract governance into leadership advantage
Disciplined governance gives executives earlier warning. It connects legal duties to staffing, technology, cash flow, quality, accreditation, and market strategy. It also produces a reliable record of what the organization did and why.
Read the related analysis on audit readiness, review areas of experience, or see the author’s background.
Source notes
- Prime Therapeutics Provider Manual for Participating Network Providers 1 (July 2026).
- Id. at 36.
- 42 C.F.R. § 423.505(i)(2)–(3) (2026).
- 21 U.S.C. § 360eee-1(d)(1)(A)(iii), (B).
- Prime Therapeutics Provider Manual, supra note 1, at 1.